vs
ClearSign Technologies Corp（CLIR）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
Profound Medical Corp.的季度营收约是ClearSign Technologies Corp的1.6倍（$6.0M vs $3.7M），ClearSign Technologies Corp净利率更高（-8.5% vs -136.8%，领先128.3%）
ClearSign Technologies是一家总部位于美国的科技企业，核心业务为排放控制技术的研发，致力于通过技术创新帮助工业领域降低污染物排放，助力实现更环保的生产运营。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
CLIR vs PROF — 直观对比
营收规模更大
PROF
是对方的1.6倍
$3.7M
净利率更高
CLIR
高出128.3%
-136.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.7M | $6.0M |
| 净利润 | $-311.0K | $-8.2M |
| 毛利率 | 21.9% | 66.8% |
| 营业利润率 | -22.5% | -123.3% |
| 净利率 | -8.5% | -136.8% |
| 营收同比 | 522.2% | — |
| 净利润同比 | 73.3% | — |
| 每股收益（稀释后） | $-0.06 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLIRPROF
| Q4 25 | $3.7M | $6.0M | ||
| Q3 25 | $1.0M | $5.1M | ||
| Q2 25 | $133.0K | $2.0M | ||
| Q1 25 | $401.0K | $2.3M | ||
| Q4 24 | $590.0K | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $45.0K | — | ||
| Q1 24 | $1.1M | — |
净利润CLIRPROF
| Q4 25 | $-311.0K | $-8.2M | ||
| Q3 25 | $-1.4M | $-8.0M | ||
| Q2 25 | $-1.7M | $-15.7M | ||
| Q1 25 | $-2.1M | $-10.7M | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-1.2M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-1.1M | — |
毛利率CLIRPROF
| Q4 25 | 21.9% | 66.8% | ||
| Q3 25 | 35.8% | 77.7% | ||
| Q2 25 | 41.4% | 81.7% | ||
| Q1 25 | 48.9% | 79.2% | ||
| Q4 24 | 14.9% | — | ||
| Q3 24 | 29.6% | — | ||
| Q2 24 | 93.3% | — | ||
| Q1 24 | 39.7% | — |
营业利润率CLIRPROF
| Q4 25 | -22.5% | -123.3% | ||
| Q3 25 | -170.1% | -176.2% | ||
| Q2 25 | -1382.0% | -696.9% | ||
| Q1 25 | -562.8% | -477.0% | ||
| Q4 24 | -282.4% | — | ||
| Q3 24 | -77.1% | — | ||
| Q2 24 | -4748.9% | — | ||
| Q1 24 | -113.6% | — |
净利率CLIRPROF
| Q4 25 | -8.5% | -136.8% | ||
| Q3 25 | -138.9% | -157.7% | ||
| Q2 25 | -1263.2% | -792.3% | ||
| Q1 25 | -517.7% | -458.1% | ||
| Q4 24 | -197.3% | — | ||
| Q3 24 | -62.1% | — | ||
| Q2 24 | -4160.0% | — | ||
| Q1 24 | -100.5% | — |
每股收益（稀释后）CLIRPROF
| Q4 25 | $-0.06 | $0.27 | ||
| Q3 25 | $-0.26 | $0.26 | ||
| Q2 25 | $-0.30 | $0.52 | ||
| Q1 25 | $-0.37 | $0.36 | ||
| Q4 24 | $-0.18 | — | ||
| Q3 24 | $-0.20 | — | ||
| Q2 24 | $-0.40 | — | ||
| Q1 24 | $-0.30 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.2M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $9.5M | $66.4M |
| 总资产 | $12.2M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资CLIRPROF
| Q4 25 | $9.2M | $59.7M | ||
| Q3 25 | $10.5M | $24.8M | ||
| Q2 25 | $12.3M | $35.2M | ||
| Q1 25 | $12.9M | $46.4M | ||
| Q4 24 | $14.0M | — | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $4.6M | — |
总债务CLIRPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CLIRPROF
| Q4 25 | $9.5M | $66.4M | ||
| Q3 25 | $9.1M | $32.1M | ||
| Q2 25 | $10.4M | $39.3M | ||
| Q1 25 | $12.0M | $50.8M | ||
| Q4 24 | $13.8M | — | ||
| Q3 24 | $14.8M | — | ||
| Q2 24 | $15.9M | — | ||
| Q1 24 | $4.5M | — |
总资产CLIRPROF
| Q4 25 | $12.2M | $77.5M | ||
| Q3 25 | $12.7M | $42.3M | ||
| Q2 25 | $14.2M | $49.7M | ||
| Q1 25 | $14.5M | $60.9M | ||
| Q4 24 | $16.3M | — | ||
| Q3 24 | $17.1M | — | ||
| Q2 24 | $17.8M | — | ||
| Q1 24 | $6.6M | — |
负债/权益比CLIRPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.3M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLIRPROF
| Q4 25 | $-1.3M | $-6.6M | ||
| Q3 25 | $-1.8M | $-9.6M | ||
| Q2 25 | $-511.0K | $-13.7M | ||
| Q1 25 | $-1.1M | $-8.3M | ||
| Q4 24 | $-415.0K | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-1.0M | — |
自由现金流CLIRPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-1.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CLIRPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -278.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CLIRPROF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
